HMC
Harvard Management Company’s AbCellera Biologics ABCL Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q2 | – | Sell |
-4,105,095
| Closed | -$31M | – | 34 |
|
|
2023
Q1 | $31M | Hold |
4,105,095
| – | – | 3.25% | 5 |
|
|
2022
Q4 | $41.6M | Hold |
4,105,095
| – | – | 5.16% | 5 |
|
|
2022
Q3 | $40.6M | Hold |
4,105,095
| – | – | 5.05% | 4 |
|
|
2022
Q2 | $43.7M | Hold |
4,105,095
| – | – | 5.06% | 4 |
|
|
2022
Q1 | $40M | Hold |
4,105,095
| – | – | 4.04% | 4 |
|
|
2021
Q4 | $58.7M | Hold |
4,105,095
| – | – | 5.51% | 5 |
|
|
2021
Q3 | $82.3M | Hold |
4,105,095
| – | – | 4.82% | 7 |
|
|
2021
Q2 | $90.3M | Hold |
4,105,095
| – | – | 5.2% | 6 |
|
|
2021
Q1 | $139M | Hold |
4,105,095
| – | – | 7.79% | 4 |
|
|
2020
Q4 | $165M | Buy |
+4,105,095
| New | +$165M | 8.96% | 4 |
|